Document 0263 DOCN M9550263 TI Synthesis and antiviral activity of new carbonylphosphonate 2',3'-dideoxy-3'-thiacytidine conjugates. DT 9505 AU Charvet AS; Turin F; Faury P; Hantz O; Camplo M; Mourier N; Berthillon P; Graciet JC; Chermann JC; Trepo C; et al; Laboratoire de Chimie Biomoleculaire, Faculte des Sciences de; Luminy, Marseille, France. SO Antiviral Res. 1994 Oct;25(2):161-8. Unique Identifier : AIDSLINE MED/95150558 AB The synthesis of new potential PFA-BCH-189 conjugate analogues is described and their molecular structure clearly identified through NMR and mass spectra techniques. The anti-HIV-1 activity was determined according to the inhibition of syncytium formation in MT-4 cells, while the anti-HBV activity was determined in infected duck hepatocytes. Both antiviral activities of the PFA-BCH-189 conjugates were much lower than those of the parent BCH-189 (2',3'-dideoxy-3'-thiacytidine) (1). Whereas a prodrug effect, following cleavage and release of the free BCH-189 and PFA, cannot be ruled out, poor cellular permeation of the drug seems to be the most likely reason for the reduced activities against HIV and DHBV. The presence of the PFA moiety appears to be detrimental for both the anti-HIV and anti-DHBV activity of PFA-BCH-189 cases. DE Animal Antiviral Agents/*CHEMICAL SYNTHESIS/*PHARMACOLOGY/ PHARMACOKINETICS Cells, Cultured Cytopathogenic Effect, Viral/DRUG EFFECTS Drug Screening Ducks Foscarnet/*PHARMACOLOGY/PHARMACOKINETICS Giant Cells/DRUG EFFECTS Hepatitis B Virus, Duck/DRUG EFFECTS Human HIV-1/*DRUG EFFECTS Liver/CYTOLOGY Molecular Structure Nuclear Magnetic Resonance Spectrum Analysis, Mass Structure-Activity Relationship Support, Non-U.S. Gov't Thionucleosides/*CHEMICAL SYNTHESIS/*PHARMACOLOGY/ PHARMACOKINETICS Zalcitabine/ANALOGS & DERIVATIVES/PHARMACOLOGY JOURNAL ARTICLE SOURCE: National Library of Medicine. NOTICE: This material may be protected by Copyright Law (Title 17, U.S.Code).